 | • レポートコード：GIR-107A14761 • 出版社/出版日：GlobalInfoResearch / 2021年7月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、T細胞特異的表面糖タンパク質CD28のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。T細胞特異的表面糖タンパク質CD28の種類別市場規模（FPT-155、FR-104、ルリズマブペゴル、その他）、用途別市場規模（尋常性乾癬、固形腫瘍、急性腎不全（ARF）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・T細胞特異的表面糖タンパク質CD28の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Atox Bio Ltd、Bristol-Myers Squibb Co、Five Prime Therapeutics Inc、Johnson & Johnson、TheraMAB LLC ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：FPT-155、FR-104、ルリズマブペゴル、その他 ・用途別分析2016年-2026年：尋常性乾癬、固形腫瘍、急性腎不全（ARF）、その他 ・T細胞特異的表面糖タンパク質CD28の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・T細胞特異的表面糖タンパク質CD28のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・T細胞特異的表面糖タンパク質CD28のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・T細胞特異的表面糖タンパク質CD28の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・T細胞特異的表面糖タンパク質CD28の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The T Cell Specific Surface Glycoprotein CD28 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global T Cell Specific Surface Glycoprotein CD28 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global T Cell Specific Surface Glycoprotein CD28 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
T Cell Specific Surface Glycoprotein CD28 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
FPT-155
FR-104
Lulizumab Pegol
Others
Market segment by Application can be divided into
Plaque Psoriasis
Solid Tumor
Acute Renal Failure(ARF)
Others
The key market players for global T Cell Specific Surface Glycoprotein CD28 market are listed below:
Atox Bio Ltd
Bristol-Myers Squibb Co
Five Prime Therapeutics Inc
Johnson & Johnson
TheraMAB LLC
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe T Cell Specific Surface Glycoprotein CD28 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of T Cell Specific Surface Glycoprotein CD28, with price, sales, revenue and global market share of T Cell Specific Surface Glycoprotein CD28 from 2019 to 2021.
Chapter 3, the T Cell Specific Surface Glycoprotein CD28 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the T Cell Specific Surface Glycoprotein CD28 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and T Cell Specific Surface Glycoprotein CD28 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe T Cell Specific Surface Glycoprotein CD28 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 T Cell Specific Surface Glycoprotein CD28 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 FPT-155
1.2.3 FR-104
1.2.4 Lulizumab Pegol
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Plaque Psoriasis
1.3.3 Solid Tumor
1.3.4 Acute Renal Failure(ARF)
1.3.5 Others
1.4 Global T Cell Specific Surface Glycoprotein CD28 Market Size & Forecast
1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Value (2016-2026))
1.4.2 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume (2016-2026)
1.4.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global T Cell Specific Surface Glycoprotein CD28 Production Capacity Analysis
1.5.1 Global T Cell Specific Surface Glycoprotein CD28 Total Production Capacity (2016-2026)
1.5.2 Global T Cell Specific Surface Glycoprotein CD28 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 T Cell Specific Surface Glycoprotein CD28 Market Drivers
1.6.2 T Cell Specific Surface Glycoprotein CD28 Market Restraints
1.6.3 T Cell Specific Surface Glycoprotein CD28 Trends Analysis
2 Manufacturers Profiles
2.1 Atox Bio Ltd
2.1.1 Atox Bio Ltd Details
2.1.2 Atox Bio Ltd Major Business
2.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product and Services
2.1.4 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bristol-Myers Squibb Co
2.2.1 Bristol-Myers Squibb Co Details
2.2.2 Bristol-Myers Squibb Co Major Business
2.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product and Services
2.2.4 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Five Prime Therapeutics Inc
2.3.1 Five Prime Therapeutics Inc Details
2.3.2 Five Prime Therapeutics Inc Major Business
2.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product and Services
2.3.4 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product and Services
2.4.4 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 TheraMAB LLC
2.5.1 TheraMAB LLC Details
2.5.2 TheraMAB LLC Major Business
2.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product and Services
2.5.4 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturer
3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in T Cell Specific Surface Glycoprotein CD28
3.4 Market Concentration Rate
3.4.1 Top 3 T Cell Specific Surface Glycoprotein CD28 Manufacturer Market Share
3.4.2 Top 6 T Cell Specific Surface Glycoprotein CD28 Manufacturer Market Share
3.5 Global T Cell Specific Surface Glycoprotein CD28 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and T Cell Specific Surface Glycoprotein CD28 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size by Region
4.1.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Region (2016-2026)
4.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2016-2026)
4.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026)
4.3 Europe T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026)
4.4 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026)
4.5 South America T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026)
4.6 Middle East and Africa T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Type (2016-2026)
5.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2016-2026)
5.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Application (2016-2026)
6.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2016-2026)
6.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2026)
7.2 North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2026)
7.3 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Country
7.3.1 North America T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2016-2026)
7.3.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2026)
8.2 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2026)
8.3 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Country
8.3.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2016-2026)
8.3.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2026)
9.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2026)
9.3 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Market Size by Region
9.3.1 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2026)
10.2 South America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2026)
10.3 South America T Cell Specific Surface Glycoprotein CD28 Market Size by Country
10.3.1 South America T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2016-2026)
10.3.2 South America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2026)
11.2 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2026)
11.3 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Market Size by Country
11.3.1 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 T Cell Specific Surface Glycoprotein CD28 Typical Distributors
12.3 T Cell Specific Surface Glycoprotein CD28 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type, (USD Million), 2021-2026
Table 2. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application, (USD Million), 2021-2026
Table 3. Atox Bio Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Atox Bio Ltd Major Business
Table 5. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 6. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Co Major Business
Table 9. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 10. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Five Prime Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 12. Five Prime Therapeutics Inc Major Business
Table 13. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 14. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 16. Johnson & Johnson Major Business
Table 17. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 18. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. TheraMAB LLC Basic Information, Manufacturing Base and Competitors
Table 20. TheraMAB LLC Major Business
Table 21. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 22. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global T Cell Specific Surface Glycoprotein CD28 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 24. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in T Cell Specific Surface Glycoprotein CD28, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global T Cell Specific Surface Glycoprotein CD28 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 27. Head Office and T Cell Specific Surface Glycoprotein CD28 Production Site of Key Manufacturer
Table 28. T Cell Specific Surface Glycoprotein CD28 New Entrant and Capacity Expansion Plans
Table 29. T Cell Specific Surface Glycoprotein CD28 Mergers & Acquisitions in the Past Five Years
Table 30. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2016-2021e) & (K Pcs)
Table 31. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2021-2026) & (K Pcs)
Table 32. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2021-2026) & (USD Million)
Table 34. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2021e) & (K Pcs)
Table 35. Global T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Pcs)
Table 36. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2021-2026) & (USD Million)
Table 38. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2016-2021e) & (USD/Pcs)
Table 39. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2021-2026) & (USD/Pcs)
Table 40. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2021e) & (K Pcs)
Table 41. Global T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Pcs)
Table 42. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2021-2026) & (USD Million)
Table 44. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2016-2021e) & (USD/Pcs)
Table 45. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2021-2026) & (USD/Pcs)
Table 46. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2016-2021e) & (K Pcs)
Table 47. North America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Pcs)
Table 48. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2021-2026) & (USD Million)
Table 50. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2021e) & (K Pcs)
Table 51. North America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Pcs)
Table 52. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2021e) & (K Pcs)
Table 53. North America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Pcs)
Table 54. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2016-2021e) & (K Pcs)
Table 55. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Pcs)
Table 56. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2021e) & (K Pcs)
Table 59. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Pcs)
Table 60. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2021e) & (K Pcs)
Table 61. Europe T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Pcs)
Table 62. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Region (2016-2021e) & (K Pcs)
Table 63. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Region (2021-2026) & (K Pcs)
Table 64. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2021e) & (K Pcs)
Table 67. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Pcs)
Table 68. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2021e) & (K Pcs)
Table 69. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Pcs)
Table 70. South America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2016-2021e) & (K Pcs)
Table 71. South America T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Pcs)
Table 72. South America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2021-2026) & (USD Million)
Table 74. South America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2021e) & (K Pcs)
Table 75. South America T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Pcs)
Table 76. South America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2021e) & (K Pcs)
Table 77. South America T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Pcs)
Table 78. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2016-2021e) & (K Pcs)
Table 79. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Country (2021-2026) & (K Pcs)
Table 80. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2016-2021e) & (K Pcs)
Table 83. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Type (2021-2026) & (K Pcs)
Table 84. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2016-2021e) & (K Pcs)
Table 85. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales by Application (2021-2026) & (K Pcs)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. T Cell Specific Surface Glycoprotein CD28 Typical Distributors
Table 89. T Cell Specific Surface Glycoprotein CD28 Typical Customers
List of Figures
Figure 1. T Cell Specific Surface Glycoprotein CD28 Picture
Figure 2. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type in 2020
Figure 3. FPT-155
Figure 4. FR-104
Figure 5. Lulizumab Pegol
Figure 6. Others
Figure 7. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application in 2020
Figure 8. Plaque Psoriasis
Figure 9. Solid Tumor
Figure 10. Acute Renal Failure(ARF)
Figure 11. Others
Figure 12. Global T Cell Specific Surface Glycoprotein CD28 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global T Cell Specific Surface Glycoprotein CD28 Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global T Cell Specific Surface Glycoprotein CD28 Sales (2016-2026) & (K Pcs)
Figure 15. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global T Cell Specific Surface Glycoprotein CD28 Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global T Cell Specific Surface Glycoprotein CD28 Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. T Cell Specific Surface Glycoprotein CD28 Market Drivers
Figure 19. T Cell Specific Surface Glycoprotein CD28 Market Restraints
Figure 20. T Cell Specific Surface Glycoprotein CD28 Market Trends
Figure 21. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Manufacturer in 2020
Figure 22. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Manufacturer in 2020
Figure 23. T Cell Specific Surface Glycoprotein CD28 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 T Cell Specific Surface Glycoprotein CD28 Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 T Cell Specific Surface Glycoprotein CD28 Manufacturer (Revenue) Market Share in 2020
Figure 26. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2016-2026)
Figure 27. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2016-2026)
Figure 28. North America T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026) & (USD Million)
Figure 29. Europe T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026) & (USD Million)
Figure 31. South America T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue (2016-2026) & (USD Million)
Figure 33. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2016-2026)
Figure 34. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2016-2026)
Figure 35. Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2016-2026)
Figure 37. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2016-2026)
Figure 38. Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2016-2026)
Figure 40. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2016-2026)
Figure 41. North America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2016-2026)
Figure 42. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2016-2026)
Figure 43. United States T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2016-2026)
Figure 47. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2016-2026)
Figure 48. Europe T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2016-2026)
Figure 49. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2016-2026)
Figure 50. Germany T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2016-2026)
Figure 59. China T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2016-2026)
Figure 66. South America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2016-2026)
Figure 67. South America T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2016-2026)
Figure 68. South America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2016-2026)
Figure 69. Brazil T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Country (2016-2026)
Figure 75. Turkey T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source